Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/24 19:21 | 10/29/24 | SYBX | Health | Drug | Pharmaceutical Preparations | Dooley Mary Beth | MA | O | Head of | S | 0 | 1.40 | 0 | 0 | -1 | 15 | D | ||||||||||||||
4/4/24 16:00 | 4/2/24 | SYBX | Health | Drug | Pharmaceutical Preparations | Dooley Mary Beth | MA | O | Head of | S | 0 | 1.73 | 0 | 0 | -1 | 15 | D | ||||||||||||||
4/4/24 16:00 | 4/2/24 | SYBX | Health | Drug | Pharmaceutical Preparations | Awad Antoine | MA | O | COO | S | -1 | 1.73 | 0 | 0 | -1 | 34 | D | ||||||||||||||
4/5/23 16:15 | 4/3/23 | SYBX | Health | Drug | Pharmaceutical Preparations | Brennan Aoife | MA | DO | See Rema | S | -11 | 0.5758 | 0 | -19 | -7 | 256 | D | ||||||||||||||
4/5/23 16:15 | 4/3/23 | SYBX | Health | Drug | Pharmaceutical Preparations | Awad Antoine | MA | O | COO | S | -4 | 0.5758 | 0 | -6 | -8 | 75 | D | ||||||||||||||
4/5/23 16:15 | 4/3/23 | SYBX | Health | Drug | Pharmaceutical Preparations | Jensen Michael Vangsted | MA | O | CFO | S | -1 | 0.5758 | 0 | -3 | -5 | 47 | D | ||||||||||||||
4/6/22 16:39 | 4/4/22 | SYBX | Health | Drug | Pharmaceutical Preparations | Brennan Aoife | MA | DO | See Rema | S | -22 | 2.45 | 0 | -9 | -3 | 275 | D | ||||||||||||||
4/6/22 16:38 | 4/4/22 | SYBX | Health | Drug | Pharmaceutical Preparations | Awad Antoine | MA | O | COO | S | -6 | 2.45 | 0 | -3 | -3 | 81 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |